2Thompson WG, Longstreth G, Drossman DA, Heaton K,Irvine E J, Muller-Lissner S. Functional bowel disorders and functional abdominal pain. In: Drossman DA,Corazziari E, Talley NJ, Thompson WG, Whitehead WE,eds. Rome Ⅱ. The functional gastrointestinal disor
3Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome Ⅱ criteria unnecessarily restrictive for research and practice? Am J Gastroenterol, 2000, 95:3176～3183.
4Ringel Y, Sperber AD, Drossman DA. Irritable bowel syndrome. Annu Rev Med, 2001, 52: 319-338.
5Thompson WG, Dotevall G, Drossman.DA, Heaton KW,Kruis W. Irritable bowel syndrome: Guidelines for the diagnosis. Gastroenterol Int, 1989, 2: 92-95.
6Agreus L. Rome? Manning? Who cares? Am J Gastroenterol, 2000, 95: 2679-2681.
7Camilleri M,Heading RC,Thompson WG, et al.Clinical perspectives,mechanisms,diagnosis and management of irritable bowel syndrome.Aliment Pharmacol Ther,2002,16(8): 1407-1430.
8Chey WD ,Olden K,Carter E,et al.Utility of the Rome Ⅰ and Rome Ⅱ criteria for irritable bowel syndrome in U S women.Am J Gastroenterol,2002,97 (11):2803-2811.
9Attar A, Lemann M, Ferguson A, et al. Comparison of a low dose ployethylene glycolelectrolyte solution with lactulose for treatment of chronic constipation Gut, 1999,44 (2): 226-230.
10Thompson WG. The treatment of irritable bowel syndrome.Aliment Pharmacol Ther,2002, 16 (8): 1395-1406.
